The Richmond Times-Dispatch recently wrote an article looking at the growing importance of biostorage in the fight for personalized cancer treatment. As cancer moves away from the all-in-one chemotherapy treatments, it's moving towards using tissue samples to personalize the treatments for the patients. The storage of tumor tissue, both before and after treatment, is key to personalizing medicine. If patients want to have access to their tissue in order to participate in clinical trials, should the be allowed to transfer the tissue?
Another key part of the article is the ownership of the tissues that are stored. Should patients have access to and ownership of their tissues that are stored in biorepositories?
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment